Literature DB >> 12811782

Novel missense mutation and large deletion of GNE gene in autosomal-recessive inclusion-body myopathy.

Roberto Del Bo1, Pierluigi Baron, Alessandro Prelle, Massimo Serafini, Maurizio Moggio, Alessio Di Fonzo, Marina Castagni, Nereo Bresolin, Giacomo Pietro Comi.   

Abstract

The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene is the causative gene for autosomal-recessive hereditary inclusion-body myopathy (h-IBM). Two sisters affected with autosomal-recessive h-IBM were shown to be compound heterozygous for two novel GNE mutations: a large deletion involving exons 1-9, and a R162C amino acid change in the epimerase domain. This is the first deletion event observed in a GNE allele and expands the molecular pathogenesis of autosomal-recessive h-IBM. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12811782     DOI: 10.1002/mus.10391

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Mutation analysis of the GNE gene in Korean patients with distal myopathy with rimmed vacuoles.

Authors:  Byoung Joon Kim; Chang-Seok Ki; Jong-Won Kim; Duk Hyun Sung; Young-Chul Choi; Seung Hyun Kim
Journal:  J Hum Genet       Date:  2005-12-22       Impact factor: 3.172

2.  Missing genetic variations in GNE myopathy: rearrangement hotspots encompassing 5'UTR and founder allele.

Authors:  Wenhua Zhu; Satomi Mitsuhashi; Takahiro Yonekawa; Satoru Noguchi; Josiah Chai Yui Huei; Atchayaram Nalini; Veeramani Preethish-Kumar; Masayoshi Yamamoto; Kenji Murakata; Madoka Mori-Yoshimura; Sachiko Kamada; Hiroyuki Yahikozawa; Masato Karasawa; Seigo Kimura; Fumitada Yamashita; Ichizo Nishino
Journal:  J Hum Genet       Date:  2016-11-10       Impact factor: 3.172

Review 3.  Mutation update for GNE gene variants associated with GNE myopathy.

Authors:  Frank V Celeste; Thierry Vilboux; Carla Ciccone; John Karl de Dios; May Christine V Malicdan; Petcharat Leoyklang; John C McKew; William A Gahl; Nuria Carrillo-Carrasco; Marjan Huizing
Journal:  Hum Mutat       Date:  2014-08       Impact factor: 4.878

Review 4.  Hereditary inclusion body myopathy: a decade of progress.

Authors:  Marjan Huizing; Donna M Krasnewich
Journal:  Biochim Biophys Acta       Date:  2009-07-24

Review 5.  GNE myopathy: current update and future therapy.

Authors:  Ichizo Nishino; Nuria Carrillo-Carrasco; Zohar Argov
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-07-07       Impact factor: 10.154

6.  Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria.

Authors:  Natalya Kurochkina; Tal Yardeni; Marjan Huizing
Journal:  Glycobiology       Date:  2009-11-16       Impact factor: 4.313

Review 7.  UDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis.

Authors:  Stephan Hinderlich; Wenke Weidemann; Tal Yardeni; Rüdiger Horstkorte; Marjan Huizing
Journal:  Top Curr Chem       Date:  2015

8.  Partial tandem duplication of mtDNA-tRNA(Phe) impairs mtDNA translation in late-onset mitochondrial myopathy.

Authors:  Paola Arzuffi; Costanza Lamperti; Erika Fernandez-Vizarra; Paola Tonin; Lucia Morandi; Massimo Zeviani
Journal:  Neuromuscul Disord       Date:  2012-01-09       Impact factor: 4.296

9.  Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study.

Authors:  Susan Sparks; Goran Rakocevic; Galen Joe; Irini Manoli; Joseph Shrader; Michael Harris-Love; Barbara Sonies; Carla Ciccone; Heidi Dorward; Donna Krasnewich; Marjan Huizing; Marinos C Dalakas; William A Gahl
Journal:  BMC Neurol       Date:  2007-01-29       Impact factor: 2.474

10.  A case report: identification of a novel exon 1 deletion mutation in the GNE gene in a Chinese patient with GNE myopathy.

Authors:  Jing Miao; Xiao-Jing Wei; Xu Wang; Xiang Yin; Xue-Fan Yu
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.